Protandim, a Fundamentally New Antioxidant Approach in Chemoprevention Using Mouse Two-Stage Skin Carcinogenesis as a Model

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Liu, Jianfeng ^a   Gu, Xin ^b   Robbins, Delira ^a   Li, Guohong ^b   Shi, Runhua ^a   McCord, Joe M ^c   Zhao, Yunfeng ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HERBACEOUS AGENT; PROTANDIM; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL TRANSFORMATION; DBA MOUSE; DIET; DRUG EFFECT; ENZYME INDUCTION; FEMALE; GEL MOBILITY SHIFT ASSAY; MOUSE; OXIDATIVE STRESS; SKIN TUMOR; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; DIET; DRUGS, CHINESE HERBAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INDUCTION; FEMALE; MICE; MICE, INBRED DBA; OXIDATIVE STRESS; SKIN NEOPLASMS; SUPEROXIDE DISMUTASE;

EID: 67649224733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005284     Document Type: Article

References (56)

1. Oberley LW, Buettner GR, (1979) Role of superoxide dismutase in cancer: a review. Cancer Res 39: 1141-1149, review.
2. Oberley LW, (2005) Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother 59: 143-148, review.
3. Apte RN, Dotan S, Elkabets M, White MR, Reich E, et al.(2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25: 387-408, review.
4. Fox JG, Wang TC, (2007) Inflammation, atrophy, and gastric cancer. J Clin Invest 117: 60-69, review.
5. Marks F, Furstenberger G, Muller-Decker K, (2007) Tumor promotion as a target of cancer prevention. Recent Results Cancer Res 174: 37-47, review.
6. Pries R, Nitsch S, Wollenberg B, (2006) Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 6: 1195-1203, review.
7. Rose-John S, Schooltink H, (2007) Cytokines are a therapeutic target for the prevention of inflammation-induced cancers. Recent Results Cancer Res 174: 57-66, review.
8. Ballaz S, Mulshine JL, (2003) The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 5: 46-62, review.
9. Farrow B, Evers BM, (2002) Inflammation and the development of pancreatic cancer. Surg Oncol 10: 153-169, review.
10. Halliwell B, (2007) Oxidative stress and cancer: have we moved forward? Biochem J 401: 1-11, review.
11. Seril DN, Liao J, Yang GY, Yang CS, (2003) Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24: 353-362, review.
12. Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM, (2006) The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med 40: 341-347.
13. Velmurugan K, Alam J, McCord JM, Pugazhenthi S, (2009) Synergistic induction of heme oxygenase-1 by the components of the dietary supplement Protandim. Free Radic Biol Med 46: 430-440.
14. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, et al.(1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847-7851.
15. Avila GE, Zheng X, Cui XX, Ryan AD, Hansson A, et al.(2005) Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice. J Pharmacol Exp Ther 315: 170-187.
16. Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, et al.(2006) Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice. Clin Cancer Res 12: 3444-3451.
17. Zhang X, Li W, Olumi AF, (2007) Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells. Clin Cancer Res 13: 7181-7190.
18. Schaar D, Goodell L, Aisner J, Cui XX, Han ZT, et al.(2006) A phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies. Cancer Chemother Pharmacol 57: 789-795.
19. Zhao Y, St Clair DK, (2003) Detection of the content and activity of the transcription factor AP-1 in a multistage skin carcinogenesis model. Methods Mol Biol 218: 177-184.
20. Oberley LW, Spitz DR, (1984) Assay of superoxide dismutase activity in tumor tissue. Methods Enzymol 105: 457-464.
21. DiDonato JA, (2000) Assaying for I kappa B kinase activity. Methods Enzymol 322: 393-400.
22. Zhao Y, Kiningham KK, Lin SM, St. Clair DK, (2001) Overexpression of MnSOD protects murine fibrosarcoma cells (FSa-II) from apoptosis and promotes a differentiation program upon treatment with 5-Azacytidine: involvement of MAPK and NFkappaB pathways. Antioxid Redox Signal 3: 375-386.
23. Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin SM, et al.(2001) Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res 61: 6082-6088.
24. Fujisawa H, Naito Y, Horiuchi S, Baba T, Otsuka F, (1992) The effects of interferon-beta on phorbol ester or calcium ionophore-induced intercellular adhesion molecule-I expression in epidermal carcinoma cells. J Dermatol 19: 78-81.
25. Dressler J, Bachmann L, Strejc P, Koch R, Muller E, (2000) Expression of adhesion molecules in skin wounds: diagnostic value in legal medicine. Forensic Sci Int 113: 173-176.
26. Cataisson C, Pearson AJ, Torgerson S, Nedospasov SA, Yuspa SH, (2005) Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo. J Immunol 174: 1686-1692.
27. Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, et al.(2002) Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res 16: 639-645.
28. Soto C, Recoba R, Barron H, Alvarez C, Favari L, (2003) Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp Biochem Physiol C Toxicol Pharmacol 136: 205-212.
29. Chaurasia SS, Panda S, Kar A, (2000) Withania somnifera root extract in the regulation of lead-induced oxidative damage in male mouse. Pharmacol Res 41: 663-666.
30. Das M, Sur P, Gomes A, Vedasiromoni JR, Ganguly DK, (2002) Inhibition of tumour growth and inflammation by consumption of tea. Phytother Res pp. S40-44.
31. Dikshit M, Rastogi L, Shukla R, Srimal RC, (1995) Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res 101: 31-35.
32. Na HK, Kim EH, Jung JH, Lee HH, Hyun JW, et al.(2008) (-)-Epigallocatechin gallate induces Nrf2-mediated-antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch Biochem Biophys 476: 171-177.
33. Jakubikova J, Sedlak J, Bod'o J, Bao Y, (2006) Effect of isothiocyanates on nuclear accumulation of NF-kappaB, Nrf2, and thioredoxin in caco-2 cells. J Agric Food Chem 54: 1656-1662.
34. Das KC, Lewis-Molock Y, White CW, (1997) Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol 17: 713-726.
35. Reagan-Shaw S, Nihal M, Ahmad N, (2008) Dose translation from animal to human studies revisited. FASEB J 22: 659-661.
36. Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, et al.(2005) p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 65: 3745-3750.
37. Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, et al.(1997) Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res 57: 1468-1474.
38. Ruckert R, Lindner G, Bulfone-Paus S, Paus R, (2000) High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol 143: 1036-1039.
39. Luo JL, Kamata H, Karin M, (2005) IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 115: 2625-2632. Review.
40. Israël A, (2003) Signal transduction: A regulator branches out. Nature 423: 596-597.
41. Baud V, Karin M, (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33-40. Review.
42. Nakanishi C, Toi M, (2005) Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5: 297-309.
43. Bauer JA, Lupica JA, Schmidt H, Morrison BH, Haney RM, et al.(2007) Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling. PLoS ONE 2: e1313.
44. Russo A, Borrelli F, (2005) Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 12: 305-317, review.
45. Gazak R, Walterova D, Kren V, (2007) Silybin and silymarin-new and emerging applications in medicine. Curr Med Chem 14: 315-338, review.
46. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG, (2003) Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci 74: 125-132.
47. Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, et al.(2004) Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7: 115-122.
48. Clark J, You M, (2006) Chemoprevention of lung cancer by tea. Mol Nutr Food Res 50: 144-151, review.
49. Fujiki H, (2005) Green tea: Health benefits as cancer preventive for humans. Chem Rec 5: 119-132, review.
50. Hoshiyama Y, Kawaguchi T, Miura Y, Mizoue T, Tokui N, et al.(2005) JACC Study Group. Green tea and stomach cancer-a short review of prospective studies. J Epidemiol Suppl 2pp. S109-112, review.
51. Stuart EC, Scandlyn MJ, Rosengren RJ, (2006) Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci 79: 2329-2336, review.
52. Wright TI, Spencer JM, Flowers FP, (2006) Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol 54: 933-946, review.
53. Narayanan BA, (2006) Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets 6: 711-727, review.
54. Sharma RA, Gescher AJ, Steward WP, (2005) Curcumin: the story so far. Eur J Cancer 41: 1955-1968, review.
55. Singh RP, Agarwal R, (2006) Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr Relat Cancer 13: 751-778, review.
56. Singh S, Khar A, (2006) Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 6: 259-270, review.